Want to join the conversation?
During 4Q15, $TMO's Specialty Diagnostics Segment revenue increased to $865MM vs. $863MM in 4Q14. Segment adjusted operating margin was 26.2% vs. 27.1% in the 2014 quarter. Laboratory Products & Services Segment revenue grew 8% to $1.82Bil vs. $1.68Bil in 4Q14. Segment adjusted operating margin increased to 14.7% vs. 14.5% in the 2014 quarter.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.